Develop and deploy AI-powered digital therapeutics (DTx) applications that provide evidence-based therapeutic interventions for mental health, chronic disease management, and rehabilitation through smartphone apps and connected devices. This moonlite targets the rapidly growing $11.6 billion digital therapeutics market driven by healthcare digitalization and the need for scalable treatment options. Revenue streams include DTx app development and licensing ($100,000-1,000,000 per therapeutic area), ongoing subscription licensing to healthcare providers ($10,000-75,000 monthly per provider network), clinical trial support and regulatory consulting ($50,000-300,000 per FDA submission), patient engagement and outcome tracking services ($2,000-15,000 monthly per provider), and value-based contracts with insurance companies based on patient outcomes. Success requires understanding of behavioral science and clinical psychology, expertise in mobile app development and AI-driven personalization, knowledge of FDA regulatory pathways for digital therapeutics, ability to design clinically validated intervention protocols, and skills in building secure, HIPAA-compliant healthcare applications that demonstrate measurable therapeutic outcomes.
